The effects of thyroid function on retinopathy of prematurity

OBJECTIVES: To assess whether TSH and fT4 have a role in the angiogenesis of vaso-obliteration and neovascularization which are the basic pathophysiology of ROP.

METHODS: In this retrospective case-control study, the control group (n = 56) included preterm newborns with risk for ROP while the laser group (n = 63) was recruited from cases who developed severe neovascularization and needed laser photocoagulation therapy. Considering the first (vaso-obliteration) and second (neovascularization) phases of the disease, in this study we researched the distribution of thyroid function tests between groups.

RESULTS: With regard to the first phase of the disease, TSH and fT4 showed no significant differences between the control and laser groups accordingly (P > 0.05). Likewise, in the second phase of ROP, there was no significant difference between the control and laser groups with respect to TSH and fT4 levels (P > 0.05).

CONCLUSION: We found that between the study groups, the levels of thyroid function tests did not have any significant differences, either in the first or the second phases of ROP which are the principal pathophysiology of the disease. Therefore, it was concluded that thyroid hormone values were not informative markers in the course of the disease in preterm babies at risk of developing ROP.

Medienart:

E-Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Journal of neonatal-perinatal medicine - 9(2016), 4 vom: 20., Seite 349-356

Sprache:

Englisch

Beteiligte Personen:

Korkmaz, Levent [VerfasserIn]
Baştuğ, Osman [VerfasserIn]
Daar, Ghaniya [VerfasserIn]
Korkut, Sabriye [VerfasserIn]
Özdemir, Ahmet [VerfasserIn]
Adnan Öztürk, Mehmet [VerfasserIn]
Güneş, Tamer [VerfasserIn]
Kurtoğlu, Selim [VerfasserIn]

Links:

Volltext

Themen:

9002-71-5
Journal Article
Q51BO43MG4
Retinopathy of prematurity
Thyroid stimulating hormone
Thyrotropin
Thyroxine
Vascular endothelial growth factor

Anmerkungen:

Date Completed 02.06.2017

Date Revised 02.06.2017

published: Print

Citation Status MEDLINE

doi:

10.3233/NPM-915150

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM26741868X